CA Stock MarketDetailed Quotes

BTI.H Bioasis Technologies Inc

Watchlist
  • 0.005
  • 0.0000.00%
15min DelayPost Market Mar 18 15:52 ET
397.07KMarket Cap-125P/E (TTM)

About Bioasis Technologies Inc Company

Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The company's in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

Company Profile

SymbolBTI.H
Company NameBioasis Technologies Inc
Founded2006
MarketTSX
Fiscal Year Ends02-29
Address157 Church Street 19th Floor
CityNew Haven
CountryUnited States of America
Zip Code06510

Company Executives

  • Name
  • Position
  • Salary
  • Deborah Ann Rathjen
  • Executive Chairman of the Board, President and Chief Executive Officer
  • --
  • Dave Jenkins
  • Chief Financial Officer
  • --
  • Dr. Mei Mei Tian, PhD
  • Vice President and Head of External Research
  • --
  • John Murray Hemeon
  • Director
  • --
  • John E. Curran
  • Independent Director
  • --
  • David M. Wurzer
  • Lead Independent Director
  • --
  • Dr. Mario Saltarelli
  • Independent Director
  • --
Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data